As concerns PAX5, its role in DLBCL has been mainly associated with the occurrence of chromosomal translocations [92] t(9;14)(p13;q32) that place PAX5 under the control of the immunoglobulin heavy chain (IGH) locus enhancers, leading to its abnormal overexpression [93]. Here, PAX5 is linked to diffuse large B-cell lymphoma.